• Mark Chen

    Mark Chen

    Mark Chen is the Senior Vice President of Portfolio and Program Management at Kriya Therapeutics. Mark joined Kriya as Director of Manufacturing Strategy and CMC Program Management, and subsequently led Manufacturing Operations. Prior to Kriya, Mark was at Biogen, where he was most recently Associate Director, Strategic Partnerships. He was responsible for the strategic relationship…

  • Wyatt Delfino, JD, PhD

    Wyatt Delfino, JD, PhD

    Wyatt Delfino is the Senior Vice President of Intellectual Property at Kriya, where he is responsible for all aspects of IP strategy and prosecution. Wyatt joined Kriya from Adverum Biotechnologies, where he most recently served as Senior Director of Intellectual Property. Prior to joining Adverum, he was an associate at Goodwin Procter LLP, a leading…